The global disposable tourniquets market size was valued at USD 443.02 million in 2025 and is projected to grow from USD 470.04 million in 2026 to USD 754.85 million by 2034, registering a CAGR of 6.1% during the forecast period from 2026 to 2034. North America dominated the disposable tourniquets market with a market share of 37.8% in 2025.
Furthermore, the import and export of disposable tourniquets also influences the market dynamics. The table below showcases the import export trend in 2024:
Low-income countries such as Africa require efficient production, low material costs, and the ability to purchase bulk disposable tourniquets for government organizations. However, countries such as Hong Kong and Malaysia import branded and premium-priced products, with stricter quality certifications and tailored designs.
The disposable tourniquets are available in two types, such as latex-free tourniquets and latex-based tourniquets, that are used during critical functions in phlebotomy and blood collection, emergency and trauma care, and surgical assistance, facilitating efficient venous access. Moreover, based on end user, these products are utilized across hospitals and clinics, diagnostic laboratories, and other medical facilities.
Download a Free Sample To learn more about this report,
Use of latex-free tourniquets gains momentum in hospital settings. BD has transitioned its entire tourniquet portfolio to exclusively latex-free materials, aligning with the hospital's broader move to eliminate latex products across its facilities. This transition addresses compliance requirements and also accelerates the adoption of latex free disposables, creating a favourable growth pathway for manufacturers.
A major trend in the disposable tourniquets market is the growing preference for disposable tourniquets, driven by stringent regulatory frameworks governing single use devices in Europe. Europe’s MDR 2017/745 tightened rules on single-use devices, with most countries banning or restricting reprocessing. France prohibits it entirely, and the UK’s strict liability framework makes re-manufacturing impractical. Even in Germany, where regulated reprocessing is allowed, compliance costs are pushing hospitals toward disposables, driving higher adoption of disposable tourniquets across key markets.
This trend reflects increasing demand for single-use disposable tourniquets.
Public blood donation drives are expanding in countries like Brazil and Mexico, creating more demand for disposable tourniquets, as it is mandatory to use tourniquets during blood withdrawal. For example, in June 2025, the Pan American Health Organization (PAHO) reported that 23 Latin American and Caribbean nations collected over 9.2 million units of blood in 2023, a 15.5% jump from 2020.
This surge in blood donations leads to increased demand for disposable tourniquets in hospitals and clinics, which, in turn, supports the market growth.
Various public buyers issue tenders that prioritize the lowest cost per unit disposable tourniquets. This impacts the margins of manufacturers that offer branded tourniquets, leading to a reduction in the profit margin, which, in turn, impacts the overall market growth.
The presence of approved medical suppliers in the U.S. and UK markets ensures that disposable tourniquets are readily available, efficiently delivered, and consistently stocked, even in rural healthcare facilities. In the U.K., the NHS Supply Chain provides various advantages to manufacturers, including reduced pricing pressures, minimized tendering time, and back office cost savings. The NHS alone uses approximately 330,000 disposable tourniquets annually within its trusts due to the strong distribution networks of below companies:
Thus, a broad distribution network presents opportunities for manufacturers to accelerate market penetration and reduce the need for building private supply chains.
The latex-based tourniquets segment dominated the market with the highest revenue share in 2025, driven by superior elasticity, tactile grip for precise venipuncture, and cost efficiency in bulk procurement. These factors make latex-based tourniquets a preferred choice in hospitals, blood donation drives, and diagnostic facilities worldwide.
The latex-free segment is projected to account for a 6.94% CAGR during the forecast period, owing to the rising adoption of eco-friendly manufacturing materials that support healthcare practices and the increasing government initiatives promoting non-toxic medical consumables to ensure safer disposal and reduced environmental impact.
Request Customizationto receive a tailored report.
The phlebotomy & blood collection segment dominated the market with a revenue share of 46.81% in 2025, owing to rising adoption of point of care testing, seamless integration with automated sample handling systems, and growing demand for rapid, standardized blood collection workflows in hospitals and diagnostic centers.
The emergency and trauma care segment is projected to grow at a CAGR of 8.36%, due to the expanding integration of tourniquet use in pre-hospital emergency protocols for rapid hemorrhage control and the rising availability of advanced disposable models tailored for field responders and military grade trauma management.
The hospital & clinics segment dominated the market with a revenue share of 42.94% in 2025. This dominance is driven by the integration of smart inventory management, which enables hospitals to track tourniquet usage in real time, preventing stockouts, reducing waste, and optimizing procurement efficiency.
The diagnostic laboratories segment is expected to grow at the fastest pace during the forecast period. This growth is stimulated by the increasing demand for high-frequency blood sampling in preventive health checkups and the growing adoption of sterile tourniquets to enhance sample accuracy and biosafety compliance in laboratory environments.
Speak to an Analystto discuss market opportunities.
North America dominated the disposable tourniquets market in 2025, accounting for 38.16% market share in 2025, driven by the widespread adoption of electronic health record integration, stringent hospital accreditation standards, and the growing its use in emergency medical services.
In Canada, the need to provide healthcare access in remote and indigenous communities drives the adoption of disposable tourniquets, as single-use devices simplify logistics and reduce cross-contamination risks in mobile clinics. Additionally, integration with provincial e-health and centralized supply chain systems enables inventory tracking, optimizing distribution across hospitals nationwide.
Unlock Regional Insightsto access country-level data, & regional trends.
Asis Pacific is emerging as a fastest-growing region with a CAGR of 7.61% from 2026-2034. This growth is augmented by the increasing hospital expansion in tier-2 and tier-3 cities, rising demand for mobile and community blood collection programs, and growing adoption of standardized procedure kits in private clinics.
In China, the disposable tourniquets market is experiencing notable growth due to the widespread adoption of thermoplastic elastomers (TPE) material, which aligns with the country's stringent medical safety standards and environmental policies. These materials not only reduce allergic reactions but also support China's commitment to guideline-compliant healthcare practices.
Europe is witnessing steady growth in the disposable tourniquets market during 2026–2034, driven by the integration of digital supply chain traceability systems that enable real-time monitoring of disposable medical devices, ensuring compliance with MDR standards while enhancing procurement transparency and safety across hospital networks and procurement agencies.
France is experiencing notable growth in the disposable tourniquets market due to the increasing adoption of hospital sustainability programs that prioritize low waste medical disposables. This shift supports the use of biodegradable and recyclable tourniquets that align with France’s national environmental and healthcare sustainability goals.
Latin America market growth in the disposable tourniquets market, driven by the expansion of regional medical device manufacturing hubs in countries such as Brazil and Argentina. These hubs attract foreign investment, enhance local production capabilities, and reduce dependence on imports, fostering affordable access to quality disposable medical consumables.
Argentina's disposable tourniquet market is growing steadily due to the increasing collaboration between public hospitals and university biomedical research centers to develop ergonomically designed, patient-friendly tourniquets. These partnerships foster innovation in material composition and usability, enhancing clinical efficiency and supporting the adoption of advanced disposable devices nationwide.
The Middle East and Africa disposable tourniquets market is growing due to the rising adoption of emergency medical response training programs by governments and NGOs, which emphasize the use of standardized disposable tourniquets in first-aid and trauma care, thereby boosting demand across public and private healthcare facilities.
South Africa’s disposable tourniquets market is growing due to the increasing adoption of public-private partnerships in hospital supply chains, which improve procurement efficiency, ensure consistent availability of disposable medical consumables, and enable faster deployment of tourniquets across both urban and rural healthcare facilities.
The global disposable tourniquet market is highly fragmented with small and regional manufacturers competing due to low production costs and widespread demand across hospitals and laboratories. Though the market is fragmented, there are few market players that account for maximum revenue share such as Medline Industries, LP, Becton, Dickinson and Company, Cardinal Health, Thermo Fisher Scientific Inc., and 9. Zimmer Biomet.
These players are responsible for shifting the market towards mild consolidation through their product offerings, centralized hospital procurements, and economies of scale.
Sanji is a Chinese domestic manufacturer of disposable tourniquets emerging as a key player in the market due to strong OEM manufacturing capabilities, cost effective production, and strong focus on the manufacturing of latex-free tourniquets. The company commercializes its products in Europe and other Asia countries. Thus, by offering high quality tourniquets, the company positions itself as a emerging manufacturer.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Her work focuses on assessing treatment landscapes, outsourcing models, technology adoption, market access dynamics, regulatory developments, and competitive positioning across healthcare and life sciences industries. Debashree has consistently supported organizations in understanding market gaps, evaluating revenue potential, developing market entry strategies, and shaping expansion plans across complex and fast evolving healthcare markets.
N95 Masks Market Size, Share, Growth, Analysis, Report, 2034
Digital X-Ray Devices Market Size, Share, Growth, Analysis, 2034
Contrast Enhanced Ultrasound Market Size, Share, Growth, 2034
Active Wound Care Market Size, Share, Growth, Forecast, 2034
Perfusion System Market Size, Share, Growth, Forecast, 2034
Medical Digital Imaging System Market Size, Share, Growth, 2034
We are featured on:
sales@straitsresearch.com